For the year ending 2025-12-31, DRMAW has $7,863,826 in assets. $1,640,446 in debts. $7,521,978 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 7,521,978 | |||
| Prepaid expenses and other current assets | 341,848 | |||
| Total assets | 7,863,826 | |||
| Accounts payable (including related party amounts of 86,250 and 0, respectively) | 460,811 | |||
| Accrued and other current liabilities (including related party amounts of 25,000 and 0, respectively) | 1,179,635 | |||
| Total liabilities | 1,640,446 | |||
| Common stock, par value 0.0001, 250,000,000 shares authorized as of december 31, 2025, and 2024 2,660,110 and 251,725 shares issued and outstanding as of december 31, 2025, and 2024, respectively | 266 | |||
| Additional paid-in capital | 79,457,010 | |||
| Accumulated deficit | -73,233,896 | |||
| Total stockholders equity | 6,223,380 | |||
| Total liabilities and stockholders equity | 7,863,826 | |||
Dermata Therapeutics, Inc. (DRMAW)
Dermata Therapeutics, Inc. (DRMAW)